Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release May 11 2021

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 11, 2021, titled "Dr. Reddy's Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India".

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases